These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2887267)

  • 1. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 4-aminopyridine and tetraethylammonium on the kinetics of transmitter release at the mammalian neuromuscular synapse.
    Saint DA
    Can J Physiol Pharmacol; 1989 Sep; 67(9):1045-50. PubMed ID: 2574628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by 4-aminopyridine of quantal acetylcholine release at the Torpedo nerve-electroplaque junction.
    Muller D
    J Physiol; 1986 Oct; 379():479-93. PubMed ID: 3031284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons.
    Rogawski MA; Barker JL
    Brain Res; 1983 Nov; 280(1):180-5. PubMed ID: 6652477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia.
    Kumamoto E; Kuba K
    J Pharmacol Exp Ther; 1985 Oct; 235(1):241-7. PubMed ID: 2413197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J; Siegel LS; Tabti N; Thesleff S
    J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 4-aminopyridine on statistical parameters of transmitter release at the neuromuscular junction.
    Lundh H
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):343-6. PubMed ID: 38626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic transmission in the guinea-pig vas deferens: the role of nerve action potentials.
    Cheung DW
    Neuroscience; 1990; 37(1):127-34. PubMed ID: 1978738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three potassium currents in mouse motor nerve terminals.
    Tabti N; Bourret C; Mallart A
    Pflugers Arch; 1989 Feb; 413(4):395-400. PubMed ID: 2928092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals.
    Dreyer F; Penner R
    J Physiol; 1987 May; 386():455-63. PubMed ID: 2445966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms underlying the repolarization of narrow and wide action potentials in pyramidal cells and interneurons of cat motor cortex.
    Chen W; Zhang JJ; Hu GY; Wu CP
    Neuroscience; 1996 Jul; 73(1):57-68. PubMed ID: 8783229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The facilitatory actions of aminopyridines and tetraethylammonium on neuromuscular transmission and muscle contractility in avian muscle.
    Harvey AL; Marshall IG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):53-60. PubMed ID: 20582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K+ and Ca2+ channel blockers may enhance or depress sympathetic transmitter release via a Ca(2+)-dependent mechanism "upstream" of the release site.
    Stjärne L; Stjärne E; Msghina M; Bao JX
    Neuroscience; 1991; 44(3):673-92. PubMed ID: 1661385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium: effects on transmitter release at the frog neuromuscular junction.
    Cooper GP; Manalis RS
    Eur J Pharmacol; 1984 Apr; 99(4):251-6. PubMed ID: 6145600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 4-aminopyridine on nerve terminal action potentials.
    Burley ES; Jacobs RS
    J Pharmacol Exp Ther; 1981 Oct; 219(1):268-73. PubMed ID: 7288611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.